Methamphetamine

1

Review clinical trials related to Methamphetamine. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Methamphetamine Isomer Pharmacology in Humans

This study is being done to understand the metabolism and impairment profile of methamphetamine (meth). Meth exists as two chemical structures that are mirror images of each other: R-meth and S-meth. S-meth is a strong central nervous system stimulant and used to treat attention deficit disorder (ADD). R-meth is not a strong central nervous system stimulant and is available over-the-counter in nasal decongestant sprays.17 healthy participants will be enrolled for 3 study visits and on study for up to 12 weeks.

Participants needed: 17
Trial details
Phase: Phase 1Age: 21-64Biological sex: AllType: InterventionalSponsor: University of Wisconsin, MadisonUpdated: Jul 1, 2026Locations: 1
Eligibility criteria

Good mental health as determined by self-reported responses to the Psychopatholo... [+3]

Any serious prior adverse response to sympathomimetic agents or amphetamine anal... [+4]